Enriching knowledge and enhancing care through health data

13 08 18

i~HD Member Mats Sundgren (AstraZeneca) about the hidden gem of Pragmatic Clinical Trials

In a recent interview in eyeforpharma, Mats Sundgren, Health Informatics Director, AstraZeneca explains how Pragmatic Clinical Trials (PCTs) are an attractive alternative to Randomised Controlled Trials. “PCTs are research investigations embedded in healthcare settings designed to increase the efficiency of research and its relevance to clinical practice.”  PCTs are gaining support in industry and academia as robust, rapid and low cost ways of gathering evidence to support clinical, regulatory and drug development decision making.  

Read the full article here: https://social.eyeforpharma.com/access-and-evidence/pragmatic-trials-rwes-hidden-gem

Learn more about Pragmatic Clinical Trials from Mats Sundgren, along with other world leading experts, at the i~HD Annual Conference this November, in Gothenburg.

Published on: 13 August 2018